EZATOR S.K. 1020 MG

Kraj: Izrael

Język: angielski

Źródło: Ministry of Health

Kup teraz

Pobierz Ulotka dla pacjenta (PIL)
07-06-2023

Składnik aktywny:

ATORVASTATIN AS CALCIUM TRIHYDRATE; EZETIMIBE

Dostępny od:

K.S.KIM INTERNATIONAL LTD

Kod ATC:

C10BA05

Forma farmaceutyczna:

FILM COATED TABLETS

Skład:

EZETIMIBE 10 MG; ATORVASTATIN AS CALCIUM TRIHYDRATE 20 MG

Droga podania:

PER OS

Typ recepty:

Required

Wyprodukowano przez:

ELPEN PHARMACEUTICAL CO. INC., GREECE

Dziedzina terapeutyczna:

ATORVASTATIN AND EZETIMIBE

Wskazania:

- Prevention of Cardiovascular EventsEzator S.K. is indicated to reduce the risk of cardiovascular events in patients with coronary heart disease (CHD) and a history of acute coronary syndrome (ACS), either previously treated with a statin or not.- HypercholesterolaemiaEzator S.K. is indicated as adjunctive therapy to diet for use in adults with primary (heterozygous familial and non-familial) hypercholesterolaemia or mixed hyperlipidaemia where use of a combination product is appropriate. • patients not appropriately controlled with a statin alone• patients already treated with a statin and ezetimibe- Homozygous Familial Hypercholesterolaemia (HoFH)Ezator S.K. is indicated as adjunctive therapy to diet for use in adults with HoFH. Patients may also receive adjunctive treatments (e.g., low-density lipoprotein [LDL] apheresis).

Data autoryzacji:

2022-11-21

Ulotka dla pacjenta

                                Patient leaflet IN ACCORDANCE WITH THE PHARMACISTS’ REGULATIONS
(PREPARATIONS) - 1986
The medicinal product is dispensed with a doctor’s prescription only
EZATOR S.K. 10 MG/10 MG
EZATOR S.K. 10 MG/20 MG
EZATOR S.K. 10 MG/40 MG
EZATOR S.K. 10 MG/80 MG
Film-coated tablets
Each film-coated tablet contains:
Ezetimibe 10 mg and atorvastatin (as calcium trihydrate) 10 mg, 20 mg,
40 mg or 80 mg.
For a list of inactive ingredients, please see Section 6, “Further
information”. See also Section 2.8,
“Important information about some of the ingredients of EZATOR
S.K..”
READ ALL OF THE LEAFLET CAREFULLY BEFORE USING THE MEDICINAL PRODUCT.
•
This leaflet contains concise information about EZATOR S.K.. If you
have more questions, ask your doctor or
pharmacist.
•
This medicinal product has been prescribed for your treatment. Do not
pass it on to others. It may harm them
even if it seems that their medical condition is similar to yours.
•
EZATOR S.K. is intended for the treatment of adults over the age of 18
years.
1. WHAT Ezator S.K. is and what it is used for
EZATOR S.K. is used, in combination with diet,
•
for the treatment of primary heterozygous familial and non-familial]
hypercholesterolemia or to reduce high levels
of blood lipids (combined hyperlipidemia) in adults patients who are:
•
not balanced using statin only; or
•
already treated using statin and ezetimibe
•
for the treatment of adult patients with hereditary disease
(homozygous familial hypercholesterolemia). The
treatment may be administered in combination with other treatments.
•
in the event of heart disease, to reduce the risk of cardiovascular
events (such as heart attack, stroke, surgery to
improve blood flow to the heart, or hospitalization due to chest
pain).
THERAPEUTIC GROUP: Ezetimibe belongs to a group of medicines called
_CAIs_ (cholesterol absorption
inhibitors), which delay the absorption of cholesterol in the
intestines. Atorvastatin belongs to a group of
medicines called statins, which are inhibitors of the enzyme HMG-
                                
                                Przeczytaj cały dokument
                                
                            

Dokumenty w innych językach

Ulotka dla pacjenta Ulotka dla pacjenta arabski 07-06-2023
Ulotka dla pacjenta Ulotka dla pacjenta hebrajski 29-11-2022

Zobacz historię dokumentów